Jay Shepard Insider Profile
4 Followers
Jay Shepard, Director at Ironwood Pharma, holds 235.04K shares in Ironwood Pharma (Ticker: IRWD), holds 164.47K shares in Esperion (Ticker: ESPR), holds 9.21K shares in Inovio Pharmaceuticals (Ticker: INO).
Jay Shepard's Trading History
| IRWDIronwood Pharma | Jun 17, 2026 | Director | Uninformative Buy | ― | $1.14M | |
| ESPREsperion | Jun 01, 2026 | ― | Uninformative Buy | ― | $523.02K | |
| INOInovio Pharmaceuticals | May 21, 2025 | Director | Uninformative Buy | 4.62K | $12.89K | |
| ARAVAravive | Apr 09, 2020 | ― | Uninformative Sell | ― | $2.45K | |
| MRNSMarinus | ― | ― | ― | $0.00 | ||
| DRRXDurect | ― | ― | ― | $0.00 |
You May Also Like
Jay Shepard insider profile FAQ
What is the percentage of profitable transactions made by Jay Shepard?
The percentage of profitable transactions made by Jay Shepard is 44%.
What is the average return per transaction made by Jay Shepard?
The average return per transaction made by Jay Shepard is -69.40%.
What stocks does Jay Shepard hold?
Jay Shepard holds: IRWD, INO, ESPR, ARAV, DRRX, MRNS stocks.
What was Jay Shepard's most profitable transaction?
Jay Shepard’s most profitable transaction was an Informative Sell of ARAV stock on May 15, 2017. The return on the trade was 91.00%.
What is Jay Shepard's role in Ironwood Pharma?
Jay Shepard's role in Ironwood Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
